REFERENCES
- Futrakul P, Sitprija V, Yenrudi S, Poshyachinda M, Sensirivatana R, Watana D, Singkhwa V, Jungthirapanich J, Futrakul N. Glomerular endothelial dysfunction determines disease progression : A hypothesis. Am J Nephrol 1997; 17: 533–540
- Thomas S E, Anderson S, Gordon K L, Oyama T T, Shankland S J, Johnson R J. Tubulointerstitial disease in aging : Evidence for underlying peritubular apillary damage, a potential role for renal ischemia. J Am Soc Nephrol 1998; 9: 231–242
- Futrakul P, Poshyachinda M, Futrakul N, Chaiwatanarat T, Sensirivatana R, Thamaree S, Watana D, Kingwatanakul D. Intrarenal hemodynamics alterations and tubular functions in nephrotic syndrome associated with focal segmental glomerulosclerosis (FSGS). A pathogenetic and therapeutic implication, V E Andreucci, Canton A Dal. Current Therapy in Nephrology, Milan, Wichtig 1993; 107–114
- Bohle A, Glomb D, Grund K E, Mackensen S. A correlation between relative interstitial volume of the renal cortex and serum creatinine concentration in minimal changes with nephrotic syndrome and in focal sclerosing glomerulonephritis. Virch Arch A Patho Anat Histol 1977; 376: 221
- Futrakul P, Poshyachinda M, yenrudi S, et al. Intrarenal hemodynamic abnormality in severe form of glomerulonephritis : Therapeutic benefit with vasodilators. J Med Assoc Thai 1992; 75: 375–385
- Bohle A, Mackensen-Haen S, Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney and Blood Press Res 1996; 19: 191–195
- Truong L D, Farhood A, Tasby J, Gillum D. Experimental chronic renal ischemia : Morphologic and immunologic studies. Kidney Int 1992; 41: 1676–1689
- Futrakul P, Poshyachinda M, Mitrakul C. Focal sclerosing glomerulonephritis : A kinetic evaluation of hemostasis and the effect of anticoagulant therapy : A controlled study. Clin Nephrol 1978; 10: 180–186
- Futrakul P, Futrakul N, Sitprija V. Enhanced renal perfusion improves function in severe nephrosis with focal segmental glomerulosclerosis. Nephrology 1995; 1: 51–57
- Ito S, Yasaki T. Effect of dipyridamole treatment in proteinuria in pediatric renal disease. Nephron 1980; 44: 174–179
- Futrakul N, Pochanugool C, Sitprija V, Singkhwa V, Futrakul P, Yenrudi S, Sensirivatana R, Watana D, Poshyachinda M. Renal dysfuncitons in glomerulonephropathy with rapidly declined renal failure. Renal Failure 1996; 18: 557–565
- De Jong P E, vander Meer J, vander Hem G K, de Zieuw D. Is the antiproteinuric effect of dipyridamole hemodynamically mediated. Nephron 1988; 50: 292–294
- Anderson S, Rennke H G, Brenner B M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in rat. J Clin Invest 1986; 77: 1993–2000
- Stefanski A, Amann K, Ritz E. To prevent progression : Ace inhibitors, calcium antagonists or both. Nephrol Dial Transplant 1995; 10: 151–152
- Marinides G N, Grogged G C, Cohen A H, Border W A. Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy. Kidney Int 1990; 37: 749–757